Bioventus Inc.

NASDAQ:BVS

Medical - Devices

Healthcare
$10.62 +2.11%

+$0.18 today

Market cap
$727.20M
Beta
0.67
P/E (TTM)
20.6
EPS (TTM)
$0.42
52W Low $5.81High $11.25

Volume 0.70M

Average 0.56M

BVS Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Bioventus Inc.NASDAQ: BVS

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 67.3M shares rose 2.0% year over year, behind the +2.5% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.0% from the prior quarter. Over 3 fiscal years it compounded at +2.8% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.0% toward the trailing-twelve-month pace of +2.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
67.3M+1.0% QoQ
Last fiscal yearDec 2025
66.62M+1.9% YoY
LTMMar 2026
66.84M+2.5% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.0%——
1 year+1.9%——
3-year CAGR+2.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
66.62M USD
Year-over-year change
+1.9%
4-year CAGR
+10.0%

Weighted Avg Shares vs competitors

How BVS compares with its peers on the latest reported figures

  • BVS's LTM Mar 2026 weighted avg shares of 66.84M shares is the 6th highest of the 9 companies compared; the peer median is 101.92M shares.
  • Its year-over-year change of +2.5% is the 3rd highest of 9, against a peer median of +0.2%.
  • Over three fiscal years its annual growth of +2.8% compares with a peer median of +4.5%.
BVS Competitors Peer median
Weighted Avg Shares for BVS and competitors
Company Period LTM YoY 3-year CAGR
SNNSmith & Nephew plcFY2025433.42M -1.1%-0.3%
MDXGMiMedx Group, Inc.LTM Mar 2026148.01M +0.6%+9.4%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026139.57M +1.9%+14.0%
ORGOOrganogenesis Holdings Inc.LTM Mar 2026127.11M -2.8%-0.9%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202676.73M -0.1%-2.6%
BVSBioventus Inc.LTM Mar 202666.84M +2.5%+2.8%
TELATELA Bio, Inc.LTM Jun 202652.94M +36.3%+42.4%
OFIXOrthofix Medical Inc.LTM Mar 202639.93M +3.4%+25.7%
ANIKAnika Therapeutics, Inc.LTM Mar 202614.15M -3.2%-0.5%
Peer median (excluding BVS) 101.92M+0.2%+4.5%

Competitors are the stored peer set for BVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue430.9M512.12M512.35M573.28M568.09M
Cost of Revenue128.19M181.04M184.15M185.05M185.66M
Gross Profit302.71M331.08M328.19M388.23M382.43M
Gross Margin70.3%64.6%64.1%67.7%67.3%
Research & Development19.04M23.85M13.45M13.64M12.11M
Selling, General & Admin254.25M332.13M303.88M327.09M311.77M
Operating Expenses290.65M498.31M409.92M400.21M323.88M
Depreciation & Amortization34.88M55.4M57.37M49.56M47.01M
EBITDA45.48M(121.61M)(23.07M)39.22M99.21M
EBITDA Margin10.6%-23.7%-4.5%6.8%17.5%
Operating Income12.06M(167.23M)(81.73M)(11.98M)58.55M
Operating Margin2.8%-32.7%-16.0%-2.1%10.3%
Interest Income00000
Interest Expense1.11M12.02M40.68M38.79M26.49M
Other Income / Expenses(2.57M)(21.79M)(39.39M)(37.15M)(32.84M)
Income Before Tax9.49M(189.03M)(121.11M)(49.13M)25.71M
Pre-Tax Margin2.2%-36.9%-23.6%-8.6%4.5%
Income Tax Expense(1.97M)(44.37M)85K(5.29M)(1.57M)
Net Income19.38M(158.7M)(156.23M)(33.54M)22.73M
Net Margin4.5%-31.0%-30.5%-5.9%4.0%
EPS (Basic)(0.15)(2.59)(2.49)(0.52)0.34
EPS (Diluted)(0.15)(2.59)(2.49)(0.52)0.33
Weighted Avg Shares45.47M61.39M62.65M65.36M66.62M
Weighted Avg Shares (Diluted)45.47M61.39M62.65M65.36M68.91M

Bioventus Inc.

NASDAQ:BVS

Intrinsic Alpha fair value

Locked

Current Price

$10.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.